<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146346">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01972386</url>
  </required_header>
  <id_info>
    <org_study_id>12-5898-CE</org_study_id>
    <nct_id>NCT01972386</nct_id>
  </id_info>
  <brief_title>EBUS/Spectrum Analysis</brief_title>
  <official_title>Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of
      lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Lymph Node Staging</measure>
    <time_frame>Pathology report will be completed as soon as possible after the procedure. (Within one year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The lymph node staging will be determined by the pathology report of the biopsy taken from the patients lymph node(s).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Spectrum Image Analysis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectrum Image Analysis using a Linear Array Ultrasound Bronchoscope</intervention_name>
    <arm_group_label>Spectrum Image Analysis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with lung cancer or suspected lung cancer who undergo EBUS TBNA for lymph node
        staging.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18 years or older

          -  Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node
             staging

        Exclusion Criteria:

          -  Patients who are deemed on clinical grounds not to be medically fit for a
             bronchoscopy

          -  Inability to give informed consent

          -  Patients who are pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexandria Grindlay, BSc, CCRP</last_name>
    <phone>416-581-7486</phone>
    <email>alexandria.grindlay@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frances Allison</last_name>
    <phone>416-581-5446</phone>
    <email>frances.allison@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandria Grindlay, BSc, CCRP</last_name>
      <phone>416-581-7486</phone>
      <email>alexandia.grindlay@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Kazuhiro Yasufuku, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 24, 2013</lastchanged_date>
  <firstreceived_date>October 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
